Cost-effectiveness of adult pneumococcal vaccination: response to Grabenstein et al
- PMID: 23318148
- DOI: 10.1016/j.vaccine.2013.01.008
Cost-effectiveness of adult pneumococcal vaccination: response to Grabenstein et al
Comment on
-
Cost-effectiveness of adult pneumococcal vaccination: responding to: Weycker D, Sato R, Strutton D, Edelsberg J, Atwood M, Jackson LA. Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50 years. Vaccine 2012;30(August (36)):5437-44.Vaccine. 2013 Mar 15;31(12):1549. doi: 10.1016/j.vaccine.2012.10.110. Epub 2012 Nov 12. Vaccine. 2013. PMID: 23153439 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical